Head and Neck Cancer Clinical Trials

RSS | Login | Register

Head and Neck Cancer Clinical Trials

Clinical Trial: Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

Clinical Trial: Phase I Trial of Metabolic Reprogramming Therapy for Treatment of Recurrent Head and Neck Cancers

Clinical Trial: Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

Clinical Trial: Comprehensive Assessment of Head and Neck Cancer Survivors (CAHNCA)

Clinical Trial: Boron Neutron Capture Therapy (BNCT) for Locally Recurrent Head and Neck Cancer

Clinical Trial: Treatment of Advanced Head and Neck Cancer

Clinical Trial: Using Fluorine-18-Labeled Fluoro-Misonidazole Positron Emission Tomography To Detect Hypoxia in Head and Neck Cancer Patients

Clinical Trial: Resistance Training and Physical Functioning in Head and Neck Cancer Patients (RETAIN)

Clinical Trial: Fludeoxyglucose F 18-PET/CT Imaging in Assessing the Tumor and Planning Neck Surgery in Patients With Newly Diagnosed Head and Neck Cancer

Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Clinical Trials: Depression and Adherence in Head and Neck Cancer

Clinical Trial: Molecular Classification of Head and Neck Tumors Using cDNA Microarray Analysis to Detect Prognosis and Response to Therapy

Clinical Trial: A Pilot Study to Evaluate Response to Neoadjuvant Chemotherapy With Cisplatin and Docetaxel Followed by Chemoradiation Therapy With Carboplatin in Stage IV Non-metastatic Head and Neck Cancer

Clinical Trial: Body Image Functioning Among Surgically Treated Patients With Head and Neck Cancer

Clinical Trial: A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

For a complete listing of clinical trials pertaining to Head and Neck Cancer via ClinicalTrials.gov, click here.

Head and Neck Cancer News

Using ESAs in patients with cancer-related anemia

New approach improves skull-base tumor surgery

MRI gives SWIFT preoperative indication of jawbone disease in oral cancer

Oncology Nurse Advisor Forum - July/August 2011

Current alcohol consumption guidelines will not prevent cancer

Discussions on Emerging Concepts and Controversies in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer

2.00 / AMA PRA Category 1 Credit(s)^TM

This program reviews developments in maintenance therapy and evaluates the relevance of tumor histology and biomarker analysis for the management of NSCLC patients.

Like to share a comment on our new site or another topic of interest to you? Click here and start typing.

Cancer care is expensive.
CancerCare can help.

Connect Booklets

twitter.com/ONAcom

Web Exclusives

Psychosocial approach useful in managing cancer pain

Delicia Honen Yard February 03, 2012

Psychosocial interventions, including skills instruction and education, can help reduce pain in persons with cancer, confirm the results of a recent meta-analysis.

Experimental agent slows progression of colorectal cancer

Delicia Honen Yard February 02, 2012

The investigational drug regorafenib conferred a statistically significant survival benefit in patients with metastatic colorectal cancer in whom no standard therapy was effective.

In HER2 breast cancer, lapatinib works better with trastuzumab than without

Delicia Honen Yard February 01, 2012

Lapatinib is not as effective as trastuzumab against (HER2)-positive breast cancer, but combining the two nearly doubles the effectiveness seen with either one alone.